# Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

> **NCT05111210** · — · RECRUITING · sponsor: **Institut Pasteur** · enrollment: 90 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **OTHER:** Blood sample
- **OTHER:** Data collection
- **OTHER:** skin biopsies

## Key facts

- **NCT ID:** NCT05111210
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-14
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111210, "Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05111210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*